High-throughput ambulatory assessment of digital reactive hyperemia: concurrent validity with known cardiovascular risk factors and potential confounding.

@article{Truschel2009HighthroughputAA,
  title={High-throughput ambulatory assessment of digital reactive hyperemia: concurrent validity with known cardiovascular risk factors and potential confounding.},
  author={Elisabeth Truschel and Marc N Jarczok and Joachim Ernst Fischer and Darcey D Terris},
  journal={Preventive medicine},
  year={2009},
  volume={49 6},
  pages={468-72}
}
OBJECTIVES Reactive hyperemia index (RHI) measurement through digital peripheral arterial tonometry (PAT) is proposed for cardiovascular disease (CVD) risk screening. We evaluated the concurrent validity of RHI, measured in a high-throughput ambulatory setting, with known CVD risk factors and biomarkers. METHODS PAT was included in the 2007 EADS/Augsburg (Germany) cohort follow-up. CVD risk factors (age, sex, hypertension, hyperlipidemia, diabetes, smoking, physical activity, prevalent… CONTINUE READING